Post by GSK

Name: #News for #investors and #media: Today we are announcing that our potential first-in-class treatment
Uploaded: 2026-04-28T06:05:49.714Z
Channel: GSK
Description: #News for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B (CHB) has been accepted for regulatory review by the US FDA. It has also

4,800,271 followers

#News for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B (CHB) has been accepted for regulatory review by the US FDA. It has also received Breakthrough Therapy designation. This marks an important step towards addressing the global burden of CHB. We are committed to reshaping the treatment landscape for people living with CHB. 🔗 Learn more: https://gsk.me/4vWUFMY

Video Content